Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Ximbio
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Ximbio
-
Ximbio proslijedio/la je Tweet
Signs of cancer can appear long before diagnosis, study shows - window of opportunity for
#earlydetection@CRUKresearch@TheCrickhttps://www.theguardian.com/science/2020/feb/05/signs-of-cancer-can-appear-long-before-diagnosis-study-shows …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ximbio proslijedio/la je Tweet
More than 80% of
#KCGS users reported advances in scientific objectives and over 50% of users have reported progression towards a potential drug therapy. You could be next! Order KCGS today athttp://theKCGS.comHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New Product launch today - Discover a new
#Kinase Chemogenomic Set from@therealKCGS https://ximbio.com/reagent/157681/the-kinase-chemogenomic-set-kcgs …#datasheet#lifesciences#reagents#inhibitorspic.twitter.com/1P7yqhnXty
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're having a great time at
@universityleeds today with our@CRUKresearch colleagues. If you're around, there's still time to drop by our stand or pop in for our talk and find out how we can help you!#techtransfer#research#lifesciencespic.twitter.com/SWoPKyT01C
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're excited to be at
@universityleeds today with our@CRUKresearch colleagues. If you're around drop by our stand or pop in for our talk and find out how we can help you!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Trying to work out if your cow or sheep vaccination has been successful? Discover a monoclonal
#antibody that could be used commercially to test for IgG immune response: https://ximbio.com/reagent/154004/anti-bovine-ovine-goat-human-igg-421-monoclonal-antibody …#lifesciences#reagentpic.twitter.com/hW1evP7zKV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you a
#researcher working with#endoplasmic reticulum,#mitochondria or other organelles? Discover 6 new#fluorescent dyes that are highly resistant to photobleaching, with low cytotoxicity: https://ximbio.com/search?q=Rezolve&tab=products …#fluorophores for#microscopy#cellularresearch#cellfiespic.twitter.com/qROK0QJ4v7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ximbio proslijedio/la je Tweet
Thank you to our Ximbassador intern Geetika and all who attened our lunch presentation on the Ximbassador program at
@uthsc!@Ximbio@UTHSCResearchpic.twitter.com/4BYCysWEZp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're delighted to announce a new partnership with
@WSUPullman! We look forward to working closely with them in the future. Discover how we can help you: https://ximbio.com/about-ximbio/technology-transfer-offices …#techtransfer#reagents#lifesciencesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ximbio proslijedio/la je Tweet
Attn.
@uthsc postdoctoral fellows and graduate students looking to gain experience in alternative careers in science. Join us tomorrow, at noon in GEB A302 to learn about an exciting internship opportunity with@UTRF and@Ximbio! https://news.uthsc.edu/announcements/learn-about-exciting-internship-opportunity-at-university-of-tennessee-research-foundation-utrf-and-ximbio/ …@UTHSCResearchpic.twitter.com/sY7iTyWU0h
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you a
#researcher working in the field of endometrial receptivity? Discover some new#antibodies from@hudsoninstitute that can provide a nonsurgical assessment: https://ximbio.com/search?q=pc6+monoclonal+antibodies&tab=products&redirect=1 …#reagents#lifesciencespic.twitter.com/YudJqwBZ53
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're delighted to announce a new partnership with the Puerto Rico Science Technology and Research Trust! We look forward to working closely with them in the future. Discover how we can help you: https://ximbio.com/about-ximbio/technology-transfer-offices …
#techtransfer#reagents#lifesciencesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Working in
#research on endometrial receptivity? Discover a range of#antibodies from@Hudson_Research that could be used in non-surgical assessments: https://ximbio.com/search?q=HtrA3+Monoclonal+antibodies&tab=products&redirect=1 …pic.twitter.com/kprdxD7BS4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're delighted to announce a new partnership with
@IDIBAPS! We look forward to working closely with them in the future. Discover how we can help you: https://ximbio.com/about-ximbio/technology-transfer-offices …#techtransfer#reagents#lifesciencesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great to see the progress of a collaboration between our
@CR_UK colleagues and one of our#techtransfer partners@LudwigInstitute: http://commercial.cancerresearchuk.org/first-human-trial-new-lung-cancer-immunotherapy …#cancer#research#lifesciencesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In a full time
#postgrad role at#NCL, but wanting to learn about alternative # careers outside of#research e.g.#techtransfer? Apply for a paid, part-time#internship: https://pages.services/campaigns.ximbio.com/ximbassador-contact-us …@UniofNewcastle@ICMNewcastle@FMSgradschool @NICR_NCL#Ximbassador@fms_postdoccommpic.twitter.com/YMDwqg0gQ3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ximbio proslijedio/la je Tweet
ICYMI: We have partnered with Vaccitech Oncology Limited (VOLT) to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer - the first viral vaccine programme to be tested in non-small cell lung cancer. Find out more: http://commercial.cancerresearchuk.org/first-human-trial-new-lung-cancer-immunotherapy?utm_source=twitter_crukresearch&utm_medium=cruksocialmedia …pic.twitter.com/jQHmvcfRV8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're delighted to announce a new partnership with East Carolina University! We look forward to working closely with them in the future. Discover how we can help you: https://ximbio.com/about-ximbio/technology-transfer-offices …
#techtransfer#reagents#lifesciences@EastCarolinaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're delighted to announce a new partnership with the University of Cincinnati! We look forward to working closely with them in the future. Discover how we can help you: https://ximbio.com/about-ximbio/technology-transfer-offices …
#techtransfer#reagents#lifesciences#UCtoaHigherDegree@uofcincyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're delighted to announce a new partnership with the University of Cape Town! We look forward to working closely with them in the future. Discover how we can help you: https://ximbio.com/about-ximbio/technology-transfer-offices …
#techtransfer#reagents#lifesciences@UCT_newsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.